Breast Cancer Information

Early Breast Cancer Detection


Most women are familiar with mammography as our "gold standard" for breast cancer screening. However, there are additional tools available that women can add to their arsenal.

One of the most effective tools in breast cancer screening is breast self-exam (BSE). However, BSE works best when women are appropriately trained in the procedure, and then followed-up with annual clinical breast exams (CBE) from their physicians. In a 2000 University of Toronto study, approximately 20,000 women were screened for breast cancer with BSE and annual CBE, and 20,000 were screened with BSE and mammograms. After more than 10 years, the BSE and annual CBE reported 610 cases of invasive breast cancer, and 105 deaths. In the BSE and mammogram group, there were 622 cases of invasive breast cancer and 107 deaths. Without question, the first line of defense against breast cancer begins with diligent BSE.

Other tools that are available to women include the AMAS (anti-malignan antibody screen) test and the NMP Nuclear matrix protein) test. Both these are blood tests that measure a certain protein in the blood that may indicate cancer. The AMAS test has been around for several years while the NMP test has not been available until only recently. Clinical trials continue in this area.

One additional tool that may detect an issue early is digital infrared thermal imaging or DITI. In 1982, the FDA approved thermography as an adjunctive tool for breast cancer screening. DITI measures heat emitted from the body and is accurate to 1/100th of a degree. DITI examines physiology, NOT structure. It is in this capacity that DITI can monitor breast HEALTH over time and alert a patient or physician to a developing problem; possibly before a lump can be seen on X-ray or palpated clinically. There are no test limitations such as breast density. DITI is a non-invasive test that does not emit radiation.

The unique characteristics of cancer allow DITI to detect breast cancer at an earlier stage of growth. As cancer is developing, it builds its own blood supply which is then reflected as increased heat in that particular region of the breast. DITI has a specificity of 83%; which reflects a problem in its early stages of development not late-stage cancer as in mammography. An abnormal thermogram carries a 10-times greater risk for cancer and a persistently abnormal thermogram carries a 22-times greater risk for cancer.

Clinical research studies continue to support thermography's role as an adjunctive tool in breast cancer screening and the ONLY tool that measures breast health over time. There are now more than 800 publications on over 300,000 women in clinical trials. A recent finding published in the American Journal of Radiology in 2003 showed that thermography has 99% sensitivity in identifying breast cancer with single examinations and limited views. Scientists concluded that a negative thermogram is powerful evidence that cancer is not present.

Thermographic screening is not covered by most insurance companies but is surprisingly affordable for most people. For more information or to find a certified clinic in your area, go to www.proactivehealthonline.com.

Brenda Witt is co-owner of Proactive Health Solutions in Southern California. She is an American College of Clinical Thermology (ACCT) certified thermographer in the Orange County area.

  


MORE RESOURCES:

KIMA CBS 29

1 in 12 teens depressed
Chicago Tribune, United States - 9 hours ago
Research has found both bad and good news on breast cancer risk. The bad news is a risk factor you can't change: Women whose sisters were diagnosed with ...
Lung Cancer Still Lowest in Federal Funding FOXBusiness
Exercise cuts breast cancer risk PRESS TV
Is Canada's geography a breast cancer risk? Globe and Mail
Vancouver Sun - Times of India
all 563 news articles


Dog Flu Diet and Diseases

Maine Breast Cancer Patients: Important Information
InjuryBoard.com, FL - 52 minutes ago
A study released by Canadian researchers on May 15, 2008 sheds new light on the possible link between vitamin D and breast cancer survival rates. ...
New Research Suggests the 'Sunshine Vitamin' Can Slow Progression ... ABC News
Vitamin D tied to cancer outcome Baltimore Sun
Vitamin D may lower breast cancer risk The News - International
Therapeutics Daily (subscription) (press release) - Washington Post
all 367 news articles


Brocktown News

Tykerb-Herceptin Combo Reduces Disease Progression
TMCnet - May 16, 2008
(BioWorld Today Via Acquire Media NewsEdge) GlaxoSmithKline plc's cancer drug candidate Tykerb worked better in heavily pre-treated breast cancer patients ...
GSK Announces Results of First Phase III Trial Evaluating Tykerb(R ... PR Newswire (press release)
all 170 news articles


Herceptin enhances Tykerb for breast cancer -study
guardian.co.uk, UK - May 15, 2008
Both drugs are designed to treat, in different ways, the 25 percent to 30 percent of breast cancer patients who have tumors that generate a protein called ...


GlxoSmithKline: Drug combo study shows positive result in treating ...
Forbes, NY - May 16, 2008
... data from a Phase III trial of the combination of two targeted agents, Tykerb and trastuzumab, in women with HER2-positive metastatic breast cancer. ...


Drug combo helps women with advanced breast cancer
The Associated Press - May 15, 2008
Liver problems also have been tied to Tykerb, which is currently approved to be used in combination with the chemo drug Xeloda for breast cancer patients ...


TopNews

Nerve Blocks Reduce Hot Flashes In Breast Cancer Survivors
FOXNews - May 16, 2008
In an experimental study, breast cancer survivors who experienced severe hot flashes underwent nerve block therapy to regulate their body’s temperature and ...
Nerve block cuts hot flashes after breast cancer Reuters
Nerve Blockers Reduce Hot Flashes In Breast Cancer Survivors Dog Flu Diet and Diseases
Anesthetic Helps Relieve Menopausal Symptoms in Breast Cancer ... Cancer Consultants
U.S. News & World Report - MedPage Today
all 68 news articles


Vitamin D and Breast Cancer - Part one
Food Consumer, IL - 2 hours ago
We summarize several reports on vitamin D and breast cancer to give readers some ideas about the importance of this vitamin. We will continue publishing ...


Nurse-administered prevention can decrease incidence of lymphedema
Hindu, India - 6 hours ago
"Women are living longer as breast cancer treatments get better, but at the same time, they face more devastating side effects like lymphedema," McDowell ...


Bone drug for breast cancer
Times of India, India - May 17, 2008
WASHINGTON: Bone drug, zoledronic acid, may help in preventing the spread of cancer in women with locally advanced breast cancer, says a new study at ...

breast cancer - Google News

Article List | Index | Site Map
All logos, trademarks and articles on this site are property and copyright of their respective owner(s).
The comments are property of their posters, all the rest is Copyright © 2006 CanadaSEEK.com - All Rights Reserved.